Aker BioMarine ASA operates a fully integrated value chain to harvest Antarctic krill and process it into high-value nutritional products. The company operates through three primary segments: Human Health Ingredients, Consumer Health Products, and Emerging Businesses. The Human Health Ingredients segment supplies B2B krill and algae oil supplements under brands like Superba and Lysoveta. The Consumer Health Products segment, operating through Lang Pharma Nutrition, manufactures private-label vitamins and supplements for major US retailers. The Emerging Businesses segment includes the consumer-facing Kori krill oil brand. In 2024, the company sold its Feed Ingredients business to focus entirely on human health solutions.